News for ORIC Pharmaceuticals, Inc. (4TZ.F)

Published at

Mar 2, 2021 12:30 PM

by thestreet.com

positive

positive

ORIC Pharmaceuticals To Participate In Upcoming Investor Conferences

SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, March 02, 2021 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company

ORIC 4TZ.MU 4TZ.F

Read more →
Published at

Jan 14, 2021 1:30 PM

by investing.com

positive

positive

Orbimed Advisors reduced stake in Alpine Immune Sciences, Inc. By Investing.com

Orbimed Advisors reduced stake in Alpine Immune Sciences, Inc.

ZA71.F ZA71.BE ORIC MRTX MRK LRMR LOGC KROS BRM.SG BRM.MU BRM.F BRM.DE BRM.BE BMYMP BMY.MX BMY ARQT ALPN 4TZ.MU 4TZ.F 34LA.MU 34LA.F 26M.SG 26M.MU 26M.F 26M.BE 0IF.MU 0IF.F 0IF.BE

Read more →
Published at

Jan 11, 2021 12:30 PM

by marketscreener.com

mixed

mixed

ORIC Pharmaceuticals Provides Corporate Update and Highlights Key 2021 Milestones

Lead program ORIC-101 continues patient enrollment investigating two therapeutic mechanisms of action and on track for two initial data readouts in 2021 Three IND/CTA filings for ORIC-533,... | January 11, 2021

4TZ.MU 4TZ.F ORIC

Read more →